RMC BANNERS SITE 2021 PENS.jpg

STATS:

  • 50.2 million (20.5%): Researchers report that 50.2 million (20.5%) U.S. adults experience chronic pain based on analysis of the new NHIS data. 1

  • Opioid Addiction: 3-million US citizens and 16 million individuals worldwide have had or currently suffer from opioid use disorder (OUD). 2

REVENUE PROJECTIONS:*

  • $50,000-$100,000 “+”/Month

FACTS/BENEFITS:

  • FDA Approved Class II Medical Device for Treatment of: Opioid Withdrawal Chronic Pain

  • Insurance Billable Model: (Medicare, Private, Workers Comp. & PIP)

  • Implantable (NOT an Acupuncture Style Unit) which allows for complete transmission of electrical impulses. 3

  • Programmable & Modulating (Interpulse)

  • Billing: Completely In-house: Eligibility, Pre-Authorization & Billing Included

  • Training: ON Site, Procedural, Educational and Complete In-Servicing

  • Marketing and Advertising Specific To each Provider's Office

INDICATIONS:

For Patients in Need Of Safe Weaning From Opioids and/or Treatment of; Chronic Pain, Neuropathic Pain/Diabetic Neuropathy, Cervical & Lumbar Pain (Neck, Back, Spine), Failed Back Surgery, or Experiencing Opioid Withdrawal

1. April 20, 2021. Brigham and Women’s Hospital. https://www.sciencedaily.com/releases/2021/04/21
2: Mohammadreza Azadfard; Martin R. Huecker; James M. Leaming. https://www.ncbi.nlm.nih.gov/books/NBK448203

3: Data and Information provided by Black Sheep Medical